PMID: 2505993Jan 1, 1989Paper

COPU regimen in the treatment of 35 esophageal cancers

Zhonghua zhong liu za zhi [Chinese journal of oncology]
W B Qi

Abstract

Thirty-five consecutive esophageal cancer patients were treated by a combination regimen COPU (CTX 600-800 mg/m2, IV, on days 1, 8, 15 at 8 PM; VCR 1.4 mg/m2, IV, on days 1, 8, 15, at 8 AM; PDD 30-40 mg/m2, IV drip on days 2, 3; UFT 4#, tid, PO. for three weeks; three weeks as a cycle and 2 cycles as a course) in our hospital from 1986 to 1987. The treatment results showed that 23 (65.7%) gave PR, 3 (8.6%) MR, 8 (22.8%) no change and 1 (2.9%) progressing. The overall response rate (CR + PR) was 65.7%. The toxicity and side effects were analyzed. The data show that COPU regimen is one of the satisfactory first line combination chemotherapy regimens at present in the management of esophageal cancer.

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.